Radiotherapy - Anastrazole Concomitant : Evaluation of the Side Effects (ORACLES)

Centre Oscar Lambret

Status: Completed

Conditions: Breast Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT01183832

ORACLES

Details and patient eligibility

About

This study is a description of the radiation effects on the healthy tissues in patients receiving Anastrozole, sequential or in association with radiotherapy.

Enrollment: 490 patients

Sex: Female

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Post-menopausal woman without superior age limit
• No metastatic breast cancer, stade I-II, estrogen receptor positive or progesterone receptor positive, treated by conservative surgery or total mastectomy and requiring additive treatment by radiotherapy and hormonotherapy
• The patients including in another clinical trial can be include in this observatory

Trial design

490 participants in 2 patient groups

Concomitant

Description:

In this group, anastrazole is concomitant to the radiotherapy

Sequential

Description:

In this group, anastrazole is sequential to the radiotherapy (start after the end of radiotherapy)